Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2021-12-13 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于股份回购期限届满暨股份回购实施结果的公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement about the completion of a share repurchase program by the company 葵花药业集团股份有限公司. It includes specifics on the repurchase plan, the number of shares repurchased, prices, compliance with regulations, and the impact on the company. It is not a financial report, earnings release, or management discussion, but rather a formal disclosure of the share buyback activity and its results. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback of its own shares.
2021-12-13 Chinese
关于召开2021年第二次临时股东大会的通知
Regulatory Filings Classification · 95% confidence The document is a detailed notice about convening the 2021 second extraordinary general meeting of shareholders for a company, including information on meeting time, location, voting procedures (both in-person and online), agenda items, and proxy forms. It does not contain financial statements or results but is focused on informing shareholders about the meeting and how to participate and vote. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA) or a Proxy Solicitation & Information Statement (PSI). However, since it is a notice about the meeting and voting procedures rather than the solicitation materials or proxy statement itself, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the shareholder meeting and voting process. The document length is under 5,000 characters, and it is not a report or transcript but a formal meeting notice and voting instructions.
2021-12-06 Chinese
关于续聘会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of an accounting firm (auditor) for the company for the 2021 fiscal year. It details the qualifications, independence, and prior work of the auditor, as well as the approval process by the board and audit committee. The document does not contain any financial statements or audit results themselves, but rather is a formal announcement about the auditor appointment. The document length is 3660 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and related information such as auditor appointments and audit firm details, excluding full annual reports. FY 2021
2021-12-06 Chinese
关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of senior management personnel at a company, including detailed biographies and qualifications of the appointed individuals. It includes statements about compliance with relevant laws and regulations, and the approval by the board of directors. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in senior management positions. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 3169 characters, which is consistent with an announcement rather than a full report.
2021-12-06 Chinese
独立董事关于第四届董事会第十二次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the 12th meeting of the 4th board of directors of a company. It includes approval of the reappointment of an audit firm and opinions on the appointment of senior management personnel. The content focuses on governance and board-level decisions rather than financial results or audit reports themselves. It does not contain financial statements or detailed financial data, nor is it a simple announcement of a report. The document aligns with Board/Management Information (MANG) as it relates to management appointments and board matters.
2021-12-06 Chinese
第四届监事会第八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding the reappointment of an audit firm for the fiscal year 2021. It includes voting results and mentions that the proposal will be submitted to the shareholders' meeting. The document is short (624 characters) and serves as an official announcement of a board decision rather than a full audit report or annual report. It does not contain financial statements or detailed audit information. Therefore, it fits best under 'Regulatory Filings' (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-12-06 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.